Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02136186 · ClinicalTrials.gov registry record · NA
Home Telemonitoring in Patients at High Risk for Readmission
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 1,380
- Enrollment target
NCT02136186: Completed NA study, sponsored by Mayo Clinic.
NCT02136186 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 1,380 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02136186, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,380 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy of home telemonitoring as an intervention to decrease hospital readmissions in patients at high risk for readmission. The overall readmission rate for high-risk MCF hospital patients is approximately 20%. Currently a system is in place to identify and score all MCF patients for their risk of readmission. This score is based on multiple variables including but not limited to: co-morbid conditions, patient's health literacy, whether they are a Medicare/Medicaid patient, their in-home social support, and whether they have had prior hospital admissions within the previous year. The literature shows that home telemonitoring of patients has had mixed results for effectiveness at preventing hospitalizations and emergency department visits. Many of these reports have restricted studies to patients with specific diseases or general characteristics; some have shown improved results while others have not. No study has examined patients who are high risk for readmission to determine if home telemonitoring for 30 days post-discharge reduces the risk for 30-day readmission.
Interventions
- DEVICE Philips Telehealth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,380 participants |
| Start Date | 2014-10 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02136186
The ClinicalTrials.gov registry entry for NCT02136186 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,380 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Philips Telehealth is the first listed.
NCT02136186 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02136186 about?
NCT02136186 is a clinical study titled "Home Telemonitoring in Patients at High Risk for Readmission". This study will evaluate the efficacy of home telemonitoring as an intervention to decrease hospital readmissions in patients at high risk for readmission. The overall readmission rate for high-risk MCF hospital patients is approximately 20%. Currently a system is in place to identify and score all ...
What is the current status of trial NCT02136186?
This trial is currently completed. It is a NA study. The enrollment target is 1,380 participants. The study started on 2014-10. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT02136186?
The interventions under investigation include: Philips Telehealth (DEVICE).
Who is sponsoring clinical trial NCT02136186?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.